Respiratory News and Research RSS Feed - Respiratory News and Research

Boehringer Ingelheim, Sutter Health announce health care innovation collaboration

Boehringer Ingelheim, Sutter Health announce health care innovation collaboration

Boehringer Ingelheim, a family-owned biopharmaceutical company, and Sutter Health, a not-for-profit health system in Northern California, today announced the start of a five-year research and health care innovation collaboration, which will explore and test the value of digital health solutions, mobile technologies, and insights from advanced data analytics in the delivery of health care. [More]
Conjoined twin boys undergo successful separation surgery

Conjoined twin boys undergo successful separation surgery

Carter and Conner, conjoined twin boys born Dec. 12, 2014, in Jacksonville, Fla., underwent a successful separation surgery on May 7, 2015. The 12-hour surgery was led by a team of highly skilled pediatric specialists that included Daniel Robie, MD, chief of pediatric general surgery, and Nicholas Poulos, MD, pediatric general surgeon, for Nemours Children's Specialty Care and Wolfson Children's Hospital. [More]
LSTM scientists one step closer to understanding why HAP increases risk of pneumonia

LSTM scientists one step closer to understanding why HAP increases risk of pneumonia

Scientists at LSTM have come a step closer to understanding why people exposed to household air pollution (HAP) are at higher risk of lung infections such as pneumonia and tuberculosis. [More]
WHO calls on experts, social media to follow best practices in naming new human infectious diseases

WHO calls on experts, social media to follow best practices in naming new human infectious diseases

WHO today called on scientists, national authorities and the media to follow best practices in naming new human infectious diseases to minimize unnecessary negative effects on nations, economies and people. [More]
GenVec reports net loss of $1.5 million for first quarter 2015

GenVec reports net loss of $1.5 million for first quarter 2015

GenVec, Inc. today reported financial results for the first quarter ended March 31, 2015. For the three months ended March 31, 2015, GenVec reported a net loss of $1.5 million, or $0.09 per share, on revenues of $0.4 million, compared with a net loss of $1.0 million, or $0.07 per share, on revenues of $2.1 million, for the same period in the prior year. [More]
Bamboo could increase spread of hantavirus, warns WSU ecologist

Bamboo could increase spread of hantavirus, warns WSU ecologist

Washington State University researchers say the popularity of bamboo landscaping could increase the spread of hantavirus, with the plant's prolific seed production creating a population boom among seed-eating deer mice that carry the disease. [More]
CHOP's patient safety team recognized for work alarm fatigue in hospital units

CHOP's patient safety team recognized for work alarm fatigue in hospital units

A patient safety team at The Children's Hospital of Philadelphia who analyzed the problem of alarm fatigue in hospital units has been recognized for the best research paper of 2014 in a journal dedicated to biomedical technology. [More]
BD reports revenues of $2.051 billion for second fiscal quarter 2015

BD reports revenues of $2.051 billion for second fiscal quarter 2015

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $2.051 billion for the second fiscal quarter ended March 31, 2015, representing a decrease of 1.0 percent from the prior-year period, or an increase of 4.9 percent on a foreign currency-neutral basis. [More]
Loyola's Ronald McDonald Children's Hospital implements pediatric early warning scoring system

Loyola's Ronald McDonald Children's Hospital implements pediatric early warning scoring system

The Ronald McDonald Children's Hospital at Loyola University Medical Center has implemented a pediatric early warning scoring system to better identify children who are at-risk of becoming critically ill while in the hospital. [More]
Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV). [More]
Researchers study early response of cells to ischemia

Researchers study early response of cells to ischemia

A group of researchers from the Lomonosov Moscow State University in collaboration with their Irish colleagues from the University College Cork has studied the early response of cells to ischemia, which is a restriction in blood supply to tissues causing the death of the cell. [More]
Mutations in PARN and RTEL1 associated with familial pulmonary fibrosis, telomere shortening

Mutations in PARN and RTEL1 associated with familial pulmonary fibrosis, telomere shortening

Researchers at UT Southwestern Medical Center have identified mutations in two genes that cause a fatal lung scarring disease known as familial pulmonary fibrosis. [More]
ResMed launches Lumis series of noninvasive ventilation devices to manage respiratory stability of patients

ResMed launches Lumis series of noninvasive ventilation devices to manage respiratory stability of patients

ResMed today announced its Lumis series of noninvasive ventilation devices that combine personalized, simplified therapy with powerful wireless connected care capabilities. The Lumis series builds upon ResMed's legacy of innovation as a new option for patients with respiratory challenges who are not dependent on continuous ventilation. [More]
Scientists test effectiveness of new method for treating COPD

Scientists test effectiveness of new method for treating COPD

Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal. [More]
Neonatal abstinence syndrome on the rise in U.S.

Neonatal abstinence syndrome on the rise in U.S.

The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period. By 2012, one infant was born every 25 minutes in the U.S. with the syndrome, accounting for $1.5 billion in annual health care charges, according to a new Vanderbilt study published in the Journal of Perinatology. [More]
Lung volume reduction surgery could improve lung function in emphysema patients

Lung volume reduction surgery could improve lung function in emphysema patients

Emphysema is a chronic, progressive, obstructive lung disease in which the small sacs of the lung (alveoli) are destroyed, leading to air pockets and severe breathing difficulties. In 2011, 4.7 million Americans reported being diagnosed with emphysema, and in 2013 more than 8200 patients died from emphysema. [More]
Adult survivors of preterm births at higher risk of developing COPD

Adult survivors of preterm births at higher risk of developing COPD

Adult survivors of preterm births may have a lung capacity that resembles the healthy elderly or casual smokers by the time they reach their early 20s, according to a University of Oregon study. [More]
Research findings pave way for development of new treatments for respiratory diseases

Research findings pave way for development of new treatments for respiratory diseases

The research has discovered a link between a vital pumping system that does not function correctly in people with cystic fibrosis and the parasite Toxoplasma. [More]
Innovative, active post-discharge intervention program benefits thoracic surgery patients

Innovative, active post-discharge intervention program benefits thoracic surgery patients

Post-surgical hospital readmission after discharge and repeat emergency room (ER) visits are not unusual for patients who have undergone major thoracic surgery. Recognizing this problem, clinicians at McMaster University have implemented an innovative, active post-discharge intervention for thoracic surgery patients that is based on the principle of a "one team-one approach" that is initiated while the patient is still hospitalized. [More]
SLU selected to work on universal flu vaccine project

SLU selected to work on universal flu vaccine project

Supported by a federal contract, Saint Louis University will study a concept for a universal flu vaccine that is designed to protect people from influenza pandemics that could turn deadly as well as seasonal flu caused by the influenza A virus. [More]
Advertisement
Advertisement